MERKEL CELL CARCINOMA OF SKIN
Clinical trials for MERKEL CELL CARCINOMA OF SKIN explained in plain language.
Never miss a new study
Get alerted when new MERKEL CELL CARCINOMA OF SKIN trials appear
Sign up with your email to follow new studies for MERKEL CELL CARCINOMA OF SKIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New virus therapy targets Hard-to-Treat cancers in first human trial
Disease control Recruiting nowThis early-phase study tests a new experimental treatment called VET3-TGI, a virus designed to attack cancer cells. It is given alone or with an immunotherapy drug (atezolizumab) to about 60 adults with advanced solid tumors that have not responded to standard treatments. The mai…
Matched conditions: MERKEL CELL CARCINOMA OF SKIN
Phase: PHASE1 • Sponsor: KaliVir Immunotherapeutics • Aim: Disease control
Last updated May 15, 2026 11:55 UTC
-
Can a simple blood test predict skin cancer outcomes?
Knowledge-focused Recruiting nowThis study looks at blood samples from 20 adults with melanoma or other skin cancers to see if certain markers in the blood can predict how well treatment works or how long people live. Participants give blood during their regular care. The goal is to find better ways to monitor …
Matched conditions: MERKEL CELL CARCINOMA OF SKIN
Sponsor: University of Wisconsin, Madison • Aim: Knowledge-focused
Last updated May 17, 2026 02:03 UTC
-
Scientists test immune cells against rare skin cancer in the lab
Knowledge-focused Recruiting nowThis study is testing a new cell therapy approach in the lab for people with Merkel cell carcinoma, a rare skin cancer linked to a virus. Researchers will take immune cells from 15 patients and see if they can be trained to attack the cancer in a test tube. The goal is to check i…
Matched conditions: MERKEL CELL CARCINOMA OF SKIN
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Knowledge-focused
Last updated May 14, 2026 12:04 UTC